Name: Ipamorelin
SKU: 58
Availability: InStock

Ipamorelin Overview

Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist. It is studied in preclinical and experimental research for its selective pituitary signaling activity with minimal off-target pathway interference. This selectivity makes it an important tool for investigating endocrine signaling, somatotroph axis modulation, and related molecular pathways.

Svensson J. et al. (1998).

History

Ipamorelin was developed in the 1990s during research into secretagogue-type peptides. Unlike earlier compounds such as GHRP-6, Ipamorelin demonstrated greater selectivity, activating target pathway signaling with minimal off-target interference. Since its discovery, it has been applied in studies investigating pituitary signaling, endocrine cascades, and downstream pathway dynamics in laboratory models.

Bowers C.Y. et al. (1997).

Ipamorelin Structure

CAS #: 170851-70-4

Molecular Formula: C₃₈H₄₉N₉O₅

Molecular Weight: 711.9 g/mol

PubChem ID: 9831659

Research Findings

Ipamorelin has been studied in endocrine, metabolic, and regenerative models, with research highlighting its activity in stimulating growth hormone release, modulating IGF-1 pathways, and supporting tissue recovery processes. Studies have also examined its role in metabolic regulation, energy balance, and cellular repair in preclinical systems.

Key Areas of Research:

Endocrine: Somatotroph axis, signaling, cascades
Signaling: Systemic markers, pathway dynamics
Molecular: Remodeling, proliferation, viability

Together, these findings suggest experimental utility for Ipamorelin across multiple biological pathways. By influencing endocrine signaling and downstream remodeling processes, Ipamorelin provides a versatile platform for research into pathway dynamics, endocrine activity, and systemic resilience in laboratory settings.

Raun K. et al., 1998